Bafna Pharmaceuticals Ltd
NSE:BAFNAPH

Watchlist Manager
Bafna Pharmaceuticals Ltd Logo
Bafna Pharmaceuticals Ltd
NSE:BAFNAPH
Watchlist
Price: 112.07 INR -4.95% Market Closed
Market Cap: 2.7B INR

Profitability Summary

Bafna Pharmaceuticals Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Bafna Pharmaceuticals Ltd

Margins Comparison
Bafna Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Bafna Pharmaceuticals Ltd
NSE:BAFNAPH
2.7B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Bafna Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Bafna Pharmaceuticals Ltd
NSE:BAFNAPH
2.7B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
524.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
274.5B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
276.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
147.2B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Bafna Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate